Progression of targeted therapy in advanced cholangiocarcinoma.
Chin J Cancer Res
; 27(2): 122-7, 2015 Apr.
Article
em En
| MEDLINE
| ID: mdl-25937773
ABSTRACT
It is necessary to establish an effective therapy to improve the survival of patients with advanced cholangiocarcinoma (CCA). Recently, with the development of pathology research in CCA, a lot of special bio-markers such as EGFR, VEGF, HER2, and MEK et al. could be over expression or mutations in CCA patients. According to their changes, combinations of targeted therapy plus chemotherapy are now recognized as effective therapies for advanced CCA. The aim of this paper is to analyze recent promising studies about targeted therapy alone or combination with each other or with chemotherapies.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Chin J Cancer Res
Ano de publicação:
2015
Tipo de documento:
Article
País de afiliação:
China